The INRAE research unit of Excellence in Microbiome Analysis

The 1st to elucidate the 2nd human genome

Accurate profiling with high resolution microbiome analysis

Diversity of experts and technologies to custom projects tailored to the partners' needs

MGP, YOUR KEY PARTNER TO ADDRESS YOUR MICROBIOME CHALLENGES

  • Biobanking

    Secure storage of samples, Recommendations to ensure high quality

  • Discovery

    Mine the microbiome as a source of innovative biocompounds

  • Pre-clinical research

    in vivo with translational animal models, ex vivo with fermenters

  • Clinical research

    Impact of your product, Stratification of individuals, Microbiome biomarkers

A certified industrial process

Quality requirement for industrial clinical studies

Validated & standardized protocols (IHMS coordinator)

Secure and automatized high-throughput pipelines

Internal R&D to improve performance

Continuous improvement to remain competitive

Partners feedback

  • « The technologies and skills developed by INRAe-MGP and BIOASTER are very complementary. This complementarity allows us to work in synergy, which proves to be profitable both in bipartite MGP-BIOASTER projects and in multipartite projects with industrial or academic partners. »

    BIOASTER

    Vincent Thomas, Head of Microbiome Program at BIOASTER

  • « I have had the opportunity to work with MGP on several occasions and in several settings. The scientific challenge is always raised while carefully taking into account the orientation desired by the industrialist. Our exchanges are always enriching and filled with good humour, which doesn’t spoil anything ! »

     

    ROQUETTE

    Clémentine Thabuis, Nutrition & Health Research Scientist at ROQUETTE

3 innovative offers

A personalized and open partnership

The protocols and procedures implemented at MGP are based on proven and published know-how and are constantly kept at the cutting edge of technology

In collaboration with industries, academics and clinics, MGP conceives and implements projects tailored to the partners’ needs:

– Consortia on research shared between different manufacturers on themes of general interest

– Donation via the Microbiome Foundation with the mention INRAE

– B2B collaboration with two types of partnership:

Our strengths

  • The best available technological tools for unparalleled acuracy

    MetaGenoPolis is a scientific excellence INRAE research unit in microbiome analysis. Our scientists were the first to explore in depth the microbial genes of the human intestinal tract – and today, they conduct standardized high-throughput DNA metagenomics analyses for applications in human and animal health.

    Learn more

    -

  • If there is something to see, we’ll see it!

    MetaGenoPolis offers end-to-end microbiome analysis services, including DNA extraction, library preparation, shotgun sequencing, quantitative and functional metagenomics, big data storage and computing facilities, bioinformatics, statistical analysis, and data interpretation – all under innovant scientific platforms, accompanied by an ethical center: UCLy (Lyon Catholic University).

    Learn more

    -

  • Tailor-made research collaborations to create intellectual property

    MetaGenoPolis drives innovation by partnering with companies from the health, pharmaceutical, nutrition, and animal health industries. We offer to your organizations a chance to work with some of the foremost scientific experts in the microbiome field, facilitating unique R&D projects that aim to create market advantages and growth.

    Learn more

    -

  • All the best french Microbiome expertises accessible to your company

    We belong to a large public INRAE ecosystem to give you the largest expertise in Microbiome: omics, vivo models, clinical data, national cohorts.

    We are a non-profit organization and this allows us to propose you the best price for the best quality (cumulative with research tax credits and other public grants).

    We continuously create successful start-ups (enterome, maat pharma and Novobiome).

    Learn more

    -

What's new

  • RECENT EVENT

    Sponsoring with exhibition stand

    read more

  • RECENT NEWS

    Parkinson’s disease research at MetaGenoPolis-INRAE receives 1.5 M$ from Aligning Science Across Parkinson’s

    read more

  • RECENT PUBLICATION

    Finlay et al. PNAS 2021
    In this publication, authors explore many facets of COVID-19−induced societal changes and their possible effects on the microbiome, and discuss current and future challenges regarding the interplay between this pandemic and the microbiome. Recent recognition of the microbiome’s influence on human health makes it critical to consider both how the microbiome, shaped by biosocial processes, affects susceptibility to the coronavirus and, conversely, how COVID-19 disease and prevention measures may affect the microbiome. This knowledge may prove key in prevention and treatment, and long-term biological and social outcomes of this pandemic.

    read more

Accept our Privacy policy*

* By submitting this contact form, MetaGenoPolis collects and processes your personal data in order to manage the response to your job applications and to answer any questions regarding our activity.
You have the right to access, rectification, object, erasure, restriction of processing, data portability and to provide instructions for the use of your data after your death.
To exercise your rights, you can contact our Data Protection Officer at cil-dpo@inrae.fr or by post at INRAE - 24, chemin de Borde Rouge –Auzeville – CS52627 – 31326 Castanet Tolosan cedex – France. For more information regarding the processing of your personal data, you can consult our privacy policy.

Suscription has been send